Summary of Purpose
Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.Read More →
The following dates are available for this trial. Trial information last updated on 7 September 2017.
|21 Apr 2017||29 Jun 2017||21 Apr 2018||21 Apr 2018||1 Sep 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|